Protective and therapeutic effects of nanoliposomal quercetin on acute liver injury in rats

Table 1 Effect of nanoliposomal quercetin on liver function in rats

Group	GPT(μ/L)	GOT(μ/L)	DBIL(μmol/L)
Normal control	33.63 ± 2.87**	59.88 ± 7.07**	0.21 ± 0.03**
Saline treatment	494.88 ± 6.53	765.50 ± 9.79	2.18 ± 0.06
Quercetin treatment	67.63 ± 6.49**	124.88 ± 14.76**	0.56 ± 0.07**
Nanoliposomal quercetin treatment	42.88 ± 3.39**^△△#	78.75 ± 8.64**^△#	0.28 ± 0.04**^△△#

Note. Data are mean ± SEM (n = 8–10). **P < 0.01, compared with Group B; ^△P < 0.05, ^△△P < 0.01, compared with Group C; ^#P > 0.05, compared with Group A, by t test
GPT glutamic-pyruvic transaminase, GOT glutamic-oxal acetic transaminase, DBIL direct bilirubin

ISSN: 2050-6511